- About Synapse
- How to Participate
- KAMJE Databases
- About Synapse
- How to Participate
- KAMJE Databases
| 1 |
Influence of Concurrent and Adjuvant Temozolomide on Health-Related Quality of Life of Patients with Grade III Gliomas: A Secondary Analysis of a Randomized Clinical Trial (KNOG-1101 Study)
Grace S. Ahn, Kihwan Hwang, Tae Min Kim, Chul Kee Park, Jong Hee Chang, Tae-Young Jung, Jin Hee Kim, Do-Hyun Nam, Se-Hyuk Kim, Heon Yoo, Yong-Kil Hong, Eun-Young Kim, Dong-Eun Lee, Jungnam Joo, Yu Jung Kim, Gheeyoung Choe, Byung Se Choi, Seok-Gu Kang, Jeong Hoon Kim, Chae-Yong Kim
Cancer Res Treat.2022;54(2):396-405. Published online 2021 July 6
DOI: http://dx.doi.org/10.4143/crt.2021.393
  |
|
| 2 |
Vincristine, Irinotecan, and Temozolomide as a Salvage Regimen for Relapsed or Refractory Sarcoma in Children and Young Adults
Hee Young Ju, Meerim Park, Jun Ah Lee, Hyeon Jin Park, Seog Yun Park, June Hyuk Kim, Hyun Guy Kang, Hee Chul Yang, Byung-Kiu Park
Cancer Res Treat.2022;54(2):563-571. Published online 2021 June 14
DOI: http://dx.doi.org/10.4143/crt.2021.178
|
|
| 3 |
Systemic Treatment of Advanced Gastroenteropancreatic Neuroendocrine Tumors in Korea: Literature Review and Expert Opinion
Changhoon Yoo, Chung Ryul Oh, Seung-Tae Kim, Woo Kyun Bae, Hye-Jin Choi, Do-Youn Oh, Myung-Ah Lee, Baek-Yeol Ryoo
Cancer Res Treat.2021;53(2):291-300. Published online 2020 December 29
DOI: http://dx.doi.org/10.4143/crt.2020.1233
|
|
| 4 |
Mutant Lin Lin, Jinquan Cai, Zixiao Tan, Xiangqi Meng, Ruiyan Li, Yang Li, Chuanlu Jiang
Cancer Res Treat.2021;53(2):367-377. Published online 2020 October 13
DOI: http://dx.doi.org/10.4143/crt.2020.506
|
|
| 5 |
Concurrent and Adjuvant Temozolomide for Newly Diagnosed Grade III Gliomas without 1p/19q Co-deletion: A Randomized, Open-Label, Phase 2 Study (KNOG-1101 Study)
Kihwan Hwang, Tae Min Kim, Chul-Kee Park, Jong Hee Chang, Tae-Young Jung, Jin Hee Kim, Do-Hyun Nam, Se-Hyuk Kim, Heon Yoo, Yong-Kil Hong, Eun-Young Kim, Dong-Eun Lee, Jungnam Joo, Yu Jung Kim, Gheeyoung Choe, Byung Se Choi, Seok-Gu Kang, Jeong Hoon Kim, Chae-Yong Kim
Cancer Res Treat.2020;52(2):505-515. Published online 2019 October 28
DOI: http://dx.doi.org/10.4143/crt.2019.421
|
|
| 6 |
FoxD2-AS1 is a prognostic factor in glioma and promotes temozolomide resistance in a O6-methylguanine-DNA methyltransferase-dependent manner
Wenbing Shangguan, Xuyang Lv, Nan Tian
Korean J Physiol Pharmacol.2019;23(6):475-482. Published online 2019 October 24
DOI: http://dx.doi.org/10.4196/kjpp.2019.23.6.475
|
|
| 7 |
High-Dose Metformin Plus Temozolomide Shows Increased Anti-tumor Effects in Glioblastoma Jung Eun Lee, Ji Hee Lim, Yong Kil Hong, Seung Ho Yang
Cancer Res Treat.2018;50(4):1331-1342. Published online 2018 January 10
DOI: http://dx.doi.org/10.4143/crt.2017.466
|
|
| 8 |
Response of Leptomeningeal Dissemination of Anaplastic Glioma to Temozolomide: Experience of Two Cases
Jin Woo Bae, Eun Kyung Hong, Ho-Shin Gwak
Brain Tumor Res Treat.2017;5(2):99-104. Published online 2017 October 31
DOI: http://dx.doi.org/10.14791/btrt.2017.5.2.99
|
|
| 9 |
Concurrent Chemoradiotherapy with Temozolomide Followed by Adjuvant Temozolomide for Newly Diagnosed Glioblastoma Patients: A Retrospective Multicenter Observation Study in Korea
Byung Sup Kim, Ho Jun Seol, Do-Hyun Nam, Chul-Kee Park, Il Han Kim, Tae Min Kim, Jeong Hoon Kim, Young Hyun Cho, Sang Min Yoon, Jong Hee Chang, Seok-Gu Kang, Eui Hyun Kim, Chang-Ok Suh, Tae-Young Jung, Kyung-Hwa Lee, Chae-Yong Kim, In Ah Kim, Chang-Ki Hong, Heon Yoo, Jin Hee Kim, Shin-Hyuk Kang, Min Kyu Kang, Eun-Young Kim, Sun-Hwan Kim, Dong-Sup Chung, Sun-Chul Hwang, Joon-Ho Song, Sung Jin Cho, Sun-Il Lee, Youn-Soo Lee, Kook-Jin Ahn, Se Hoon Kim, Do Hun Lim, Ho-Shin Gwak, Se-Hoon Lee, Yong-Kil Hong
Cancer Res Treat.2017;49(1):193-203. Published online 2016 June 27
DOI: http://dx.doi.org/10.4143/crt.2015.473
|
|
| 10 |
Continuous Low-Dose Temozolomide Chemotherapy and Microvessel Density in Recurrent Glioblastoma
Jong-Yun Woo, Seung Ho Yang, Youn Soo Lee, Su Youn Lee, Jeana Kim, Yong Kil Hong
J Korean Neurosurg Soc.2015;58(5):426-431. Published online 2015 November 30
DOI: http://dx.doi.org/10.3340/jkns.2015.58.5.426
|
|
| 11 |
Prediction of Response to Concurrent Chemoradiotherapy with Temozolomide in Glioblastoma: Application of Immediate Post-Operative Dynamic Susceptibility Contrast and Diffusion-Weighted MR Imaging
Eun Kyoung Lee, Seung Hong Choi, Tae Jin Yun, Koung Mi Kang, Tae Min Kim, Se-Hoon Lee, Chul-Kee Park, Sung-Hye Park, Il Han Kim
Korean J Radiol.2015;16(6):1341-1348. Published online 2015 October 26
DOI: http://dx.doi.org/10.3348/kjr.2015.16.6.1341
|
|
| 12 |
Validation of the Effectiveness and Safety of Temozolomide during and after Radiotherapy for Newly Diagnosed Glioblastomas: 10-year Experience of a Single Institution
Jin-Deok Joo, Hansol Kim, Young-Hoon Kim, Jung Ho Han, Chae-Yong Kim
J Korean Med Sci.2015;30(11):1597-1603. Published online 2015 October 16
DOI: http://dx.doi.org/10.3346/jkms.2015.30.11.1597
|
|
| 13 |
The Effect of Chemoradiotherapy with SRC Tyrosine Kinase Inhibitor, PP2 and Temozolomide on Malignant Glioma Cells Keun-Yong Eom, Bong Jun Cho, Eun Jung Choi, Jin-Ho Kim, Eui Kyu Chie, Hong-Gyun Wu, Il Han Kim, Sun Ha Paek, Jae-Sung Kim, In Ah Kim
Cancer Res Treat.2016;48(2):687-697. Published online 2015 June 4
DOI: http://dx.doi.org/10.4143/crt.2014.320
|
|
| 14 |
Combination Therapy for Gliomas Using Temozolomide and Interferon-Beta Secreting Human Bone Marrow Derived Mesenchymal Stem Cells
Jae-Hyun Park, Chung Heon Ryu, Mi Jin Kim, Sin-Soo Jeun
J Korean Neurosurg Soc.2015;57(5):323-328. Published online 2015 May 31
DOI: http://dx.doi.org/10.3340/jkns.2015.57.5.323
|
|
| 15 |
Toxic Epidermal Necrolysis in Polymedicated Patient Treated With Radiotherapy
Remedios Pérez-Calderón, M. Angeles Gonzalo-Garijo, Silvia Corrales-Vargas, Gloria Jiménez-Ferrera, Isabel Rodríguez-Nevado, Mario Díaz-Delgado
Allergy Asthma Immunol Res.2015;7(2):199-201. Published online 2014 September 19
DOI: http://dx.doi.org/10.4168/aair.2015.7.2.199
|
|
| 16 |
Toxicity Profile of Temozolomide in the Treatment of 300 Malignant Glioma Patients in Korea
So Hyun Bae, Min-Jung Park, Min Mi Lee, Tae Min Kim, Se-Hoon Lee, Sung Yun Cho, Young-Hoon Kim, Yu Jung Kim, Chul-Kee Park, Chae-Yong Kim
J Korean Med Sci.2014;29(7):980-984. Published online 2014 July 11
DOI: http://dx.doi.org/10.3346/jkms.2014.29.7.980
|
|
| 17 |
Glioblastoma in a Patient with Neurofibromatosis Type 1: A Case Report and Review of the Literature
Tae-Seok Jeong, Gi-Taek Yee
Brain Tumor Res Treat.2014;2(1):36-38. Published online 2014 April 29
DOI: http://dx.doi.org/10.14791/btrt.2014.2.1.36
|
|
| 18 |
Temozolomide Salvage Chemotherapy for Recurrent Anaplastic Oligodendroglioma and Oligo-Astrocytoma
Ho-Shin Gwak, Gi Taek Yee, Chul-Kee Park, Jin Wook Kim, Yong-Kil Hong, Seok-Gu Kang, Jeong Hoon Kim, Ho Jun Seol, Tae-Young Jung, Jong Hee Chang, Heon Yoo, Jeong-Hyun Hwang, Se-Hyuk Kim, Bong Jin Park, Sun-Chul Hwang, Min Su Kim, Seon-Hwan Kim, Eun-Young Kim, Ealmaan Kim, Hae Yu Kim, Young-Cho Ko, Hwan Jung Yun, Ji Hye Youn, Juyoung Kim, Byeongil Lee, Seung Hoon Lee
J Korean Neurosurg Soc.2013;54(6):489-495. Published online 2013 December 31
DOI: http://dx.doi.org/10.3340/jkns.2013.54.6.489
|
|
| 19 |
Current Trends in Glioblastoma Multiforme Treatment: Radiation Therapy and Immune Checkpoint Inhibitors
Sarah Nicholas, Dimitris Mathios, Jacob Ruzevick, Christopher Jackson, Isaac Yang, Michael Lim
Brain Tumor Res Treat.2013;1(1):2-8. Published online 2013 April 30
DOI: http://dx.doi.org/10.14791/btrt.2013.1.1.2
|
|
| 20 |
Temozolomide during and after Radiotherapy for Newly Diagnosed Glioblastomas : A Prospective Multicenter Study of Korean Patients
Jin-Deok Joo, Jong Hee Chang, Jeong Hoon Kim, Yong-Kil Hong, Young-Hoon Kim, Chae-Yong Kim
J Korean Neurosurg Soc.2012;52(2):92-97. Published online 2012 August 31
DOI: http://dx.doi.org/10.3340/jkns.2012.52.2.92
|
|